The Valley Desk

NCT00953147 · Interventional trial

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Overall registry status Completed

Phase 3

Conditions Allergic Rhinitis, Perennial Allergic Rhinitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov